MOLECULAR STUDY OF CALR GENE: MYELOPROLIFERATIVE NEOPLASMS (MPN) WITH NEGATIVE PHILADELPHIA AND JAK2/V617F

被引：0
|
作者：
Culurgioni, F. [1 ]
Musiu, C. [1 ]
Uda, S. [1 ]
Benziane, A. [1 ]
Pettinau, M. [1 ]
Usala, E. [1 ]
Cabras, M. G. [1 ]
机构：
[1] Ctr Trapianti Midollo Osseo PO A Businco Ao Brotz, Unita Operat Ematol, Cagliari, Italy
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PU039
引用
收藏
页码：167 / 168
页数：2
相关论文
共 50 条
  • [1] Quantitative assessment of JAK2 V617F and CALR mutations in Philadelphia negative myeloproliferative neoplasms
    Gango, Ambrus
    Mozes, Reka
    Boha, Zsofia
    Kajtar, Bela
    Timar, Botond
    Kiraly, Peter Attila
    Kiss, Richard
    Fesus, Viktoria
    Nagy, Noemi
    Demeter, Judit
    Korosmezey, Gabor
    Borbenyi, Zita
    Marton, Imelda
    Szoke, Anita
    Masszi, Tamas
    Farkas, Peter
    Varkonyi, Judit
    Plander, Mark
    Posfai, Eva
    Egyed, Miklos
    Pal, Katalin
    Radvanyi, Gaspar
    Hamed, Aryan
    Csomor, Judit
    Matolcsy, Andras
    Alpar, Donat
    Bodor, Csaba
    LEUKEMIA RESEARCH, 2018, 65 : 42 - 48
  • [2] CALR mutations in a cohort of JAK2 V617F negative patients with suspected myeloproliferative neoplasms
    Tanja Belcic Mikic
    Tadej Pajic
    Matjaz Sever
    Scientific Reports, 9
  • [3] CALR mutations in a cohort of JAK2 V617F negative patients with suspected myeloproliferative neoplasms
    Mikic, Tanja Belcic
    Pajic, Tadej
    Sever, Matjaz
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [4] Coexistence of lymphoproliferative and myeloproliferative neoplasms with simultaneous CALR and JAK2 V617F mutations
    Yang, Hai-Su
    CANCER BIOMARKERS, 2016, 17 (04) : 383 - 389
  • [5] Screening for CALR gene mutations in Jak-2 V617F mutation negative patients with myeloproliferative neoplasms
    Ulusal, S. Demir
    Umit, E. G.
    Gurkan, H.
    Tozkir, H.
    Baysal, M.
    Goncu, E.
    Eker, D.
    Demir, A. M.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2018, 26 : 907 - 908
  • [6] The JAK2 V617F mutation in Philadelphia-negative chronic myeloproliferative disorders
    Stoj, Anastazja
    Rudzki, Zbigniew
    Stachura, Jerzy
    Sacha, Tomasz
    Czekalska, Sylwia
    JOURNAL OF CLINICAL PATHOLOGY, 2007, 60 (09) : 1070 - 1071
  • [7] Low Level JAK2 V617F Is Significant in Confirming a Clinical Suspicion of Myeloproliferative Neoplasms (MPN)
    Chevarie-Davis, M.
    Riley, A. C.
    Lopategui, J.
    MODERN PATHOLOGY, 2014, 27 : 342A - 342A
  • [8] A Prolonged Low Level JAK2 V617F Is Significant In Clinically Suspicious Myeloproliferative Neoplasms (MPN)
    Vail, E.
    Chevarie-Davis, M.
    Riley, C.
    Lopategui, J.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2017, 19 (06): : 957 - 958
  • [9] Low Level JAK2 V617F Is Significant in Confirming a Clinical Suspicion of Myeloproliferative Neoplasms (MPN)
    Chevarie-Davis, M.
    Riley, A. C.
    Lopategui, J.
    LABORATORY INVESTIGATION, 2014, 94 : 342A - 342A
  • [10] JAK2 V617F Impairs Lymphoid Differentiation in Myeloproliferative Neoplasms
    Choi, Daniel C.
    Abu-Zeinah, Ghaith
    Kermani, Pouneh
    Messali, Nassima
    Yabut, Maria Mia
    Erdos, Katie
    Scandura, Joseph M.
    BLOOD, 2023, 142
12345